Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: Effect of duration of the treatment

Transplantation

Volumn 75, Issue 1, 2003, Pages 31-36

  Ozer, Kagan ^a   Oke, Ramadan ^a   Gurunluoglu, Raffi ^a   Zielinski, Maciej ^a   Izycki, Dariusz ^a   Prajapati, Rita ^a   Siemionow, Maria ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SKIN TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FLOW CYTOMETRY; GRAFT SURVIVAL; HINDLIMB; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED LEW; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037439958     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200301150-00006     Document Type: Article

References (30)

1. Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N Engl J Med. 2000; 343(7): 468.
2. Alison AC. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000; 47: 63.
3. Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401.
4. Foster RP, Fan L, Niepp M, et al. Donor specific tolerance induction in composite tissue allografts. Am J Surg 1998; 176: 418.
5. Gammie JS, Li S, Colson YL, et al. A partial conditioning strategy for achieving mixed chimerism in rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol 1998; 26: 927.
6. Gyopar AF, Loertscher R, Guttman RD, et al. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine. Transplantation 1993; 55: 1199.
7. Hewitt CW, Llull R, Patel MP, et al. Mechanisms of unresponsiveness associated with pretransplant blood transfusion-cyclosporine-induced mixed lymphocyte chimerism. Transpl Int 1994; 7: S559.
8. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum: VII. Optimal cellular antigen for induction of immunological tolerance with antilymphocyte serum. Transplant Proc 1970; 2: 489.
9. Wood ML, Monaco AP, Gozzo JJ, et al. Use of homozygous allogenic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1970; 3: 676.
10. Caridis T, Liegeois A, Barrett I, et al. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 1973; 5: 671.
11. Thomas J, Carver FM, Foil MB, et al. Renal allograft tolerance induced with ATG and donor bone marrow in out bred rhesus monkeys. Transplantation 1983; 36: 104.
12. Monaco AP, Wood ML, Maki T, et al. Attempt to induce unresponsiveness to human renal allografts with antilymphocyte globulin and donor specific bone marrow. Transplant Proc 1985; 17: 1312.
13. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
14. Ricordi C, Karatzas T, Nery J, et al. High dose bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997; 63: 7.
15. Hewitt CW, Black KS, Dowdy SF, et al. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation 1986; 41: 39.
16. Hewitt CW, Ramsamooj R, Patel MP, et al. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 1990; 50: 766.
17. Janczewska S, Ziolkowska A, Durlik M, et al. Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats. Transplantation 1999; 68: 201.
18. Talmor M, Steinman RM, Codner MA, et al. Bone marrow-derived chimerism in non-irradiated, cyclosporin-treated rats receiving microvascular limb transplants: evidence for donor-derived dendritic cells in recipient lymphoid tissues. Immunology 1995; 86: 448.
19. Hale DA, Gottschalk R, Umemura A, et al. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 2000; 69: 1242.
20. Press BH, Sibley RK, Shons AR. Limb allotransplantation in the rat: extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression. Ann Plast Surg 1986; 16: 313.
21. Billingham R, Brent L. A simple method for inducing tolerance of skin homografts in mice. Trans Bull 1957; 4: 67.
22. Lee LA, Sergio JJ, Sachs DH, et al. Mechanism of tolerance in mixed xenogenic chimeras prepared with a nonmyeloablative conditioning regimen. Transplant Proc 1994; 26: 1197.
23. Li H, Colson YL, Ildstad ST. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 1995; 60: 523.
24. Ildstad ST, Boggs SS, Vecchini F, et al. Mixed xenogenic chimeras (rat + mouse to mouse): evidence of rat stem cell engraftment, strain specific transplantation tolerance, and skin-specific antigens. Transplantation 1992; 53(4): 815.
25. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
26. Fliedner TM, Calvo W, Klinnert V, et al. Bone marrow structure and its possible significance for hematopoietic cell renewal. Ann N Y Acad Sci 1985; 459: 73.
27. Llull R, Ramsamooj R, Black KS, et al. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants. Transpl Int 1994; 7: S453.
28. Hashimoto F, Sugiura K, Inoue K, et al. MHC complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997; 89: 49.
29. Ishida T, Inaba M, Hisha H, et al. Requirement of donor-derived stromal cells for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune disease in MRL/MP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1993; 152: 3119.
30. Black KS, Hewitt CW, Hwang JS, et al. Dose response of cyclosporinetreated composite tissue allografts in a strong histoincompatible rat model. Transplant Proc 1988; 20(2 Suppl 2): 266.